ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Educational Symposium

Updates on Therapeutic Options for Anemia in Kidney Diseases

November 03, 2022 | 12:45 PM - 01:45 PM

Location: Regency Ballroom T, Hyatt Regency Orlando

Session Description

Anemia is an important and frequent complication of CKD that is often poorly diagnosed and undertreated in patients with early-stage CKD. When left untreated or undertreated, anemia due to CKD is associated with poor clinical outcomes and leads to a substantial burden on patients and healthcare systems.

This symposium provides an update on anemia treatment options for patients with non–dialysis-dependent CKD. The symposium also provides insights on the safety and efficacy of hypoxia-inducible factor–prolyl hydroxylase inhibitors (HIF-PHIs).

Support is provided by an educational grant from GlaxoSmithKline.

Learning Objective(s)

  • Discuss management options to treat anemia in nondialysis CKD
  • Analyze the cardiovascular complications of treating anemia
  • Compare the efficacy of HIF-PHIs with erythropoiesis-stimulating agents

Learning Pathway(s)

  • CKD Non-Dialysis


  • Fredric O. Finkelstein, MD


  • Introduction
    12:45 PM - 12:55 PM
    Fredric O. Finkelstein, MD
  • Management of Anemia in Nondialysis CKD: Current Recommendations
    12:55 PM - 01:15 PM
    Bruce M. Robinson, MD, MS, FASN
  • Efficacy and Cardiovascular Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors
    01:15 PM - 01:35 PM
    Nupur Gupta, MD
  • Questions and Answers
    01:35 PM - 01:45 PM